Swing Trading Plan
Holding Period
1-6 trading days
Expected figures are probability-weighted from our historical pattern database; Trade R:R is measured from the entry, target and stop levels.
Current Setup
CRDO has formed a bullish pennant following strong earnings beats—Q4 FY2026 EPS of $1.16 beat consensus by 13.73%, and non-GAAP net income reached $226.7 million on $437M revenue. The pattern consolidates between key support at $177.0 and resistance at $286.24, with current price at $234.82. Structure score of 15/15 reflects textbook pennant geometry. Breakout score of 13/13 confirms impending directional move, though volume score of 11/12 shows slightly below-average participation (0.93 relative volume). Overall score of 78/98 and 61.58% win probability suggest a technically sound setup with moderate confidence.
Stock Context
Credo completed the DustPhotonics acquisition on May 28, 2026, integrating silicon photonics technology to establish a vertically integrated 800G–3.2T optical stack for hyperscale AI data centers. Fiscal 2026 results beat expectations with $437M Q4 revenue up 157% year-over-year. 19 analysts rate CRDO as 'Strong Buy' with a 12-month target of $283.23, implying 20.76% upside. Barclays raised its price target to $300 from $260. The stock rallied from $177 in late July to $282.82 by mid-August 2026, demonstrating strong momentum with shallow pullbacks. Credo will report Q1 FY2027 earnings on September 1, 2026—catalyst is imminent.
What to Expect
A successful breakout above $286.24 resistance would target the conservative measure of $252.35 initially, though historical pennants in AI semiconductor names often achieve the full measured move. Volume confirmation requires a spike above the 5.2M average as price breaks above resistance. The pattern invalidates below key support at $177.0—a 24.6% downside from current price. With a 61.58% win probability and bullish market regime (0.81 score), the risk/reward favors breakout success. ATR of 23.45 suggests typical daily swings of ~10%, so traders should anticipate volatility during the breakout.
Risk Factors
Recent analyst upgrades and media attention have sharpened debate on whether the stock's strong recent move is pricing in all positive catalysts. Beta of 2.62 and 20-day volatility of 1.15 indicate high sensitivity to broad market pullbacks—any correction in tech could trigger sharp reversals. Q4 results noted some pressure on gross margins from scaling and supply chain factors, flagging execution risks ahead. RSI at 48.85 shows neutral momentum, not overbought, mitigating near-term exhaustion risk. The stock fell 12.43% in the past week despite the bullish pattern, suggesting recent profit-taking. Earnings on September 1, 2026 carry binary risk—a miss could invalidate the technical setup entirely.
How We Find and Score This Setup
We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.
Frequently Asked Questions
Is CRDO a good swing trade?
CRDO scored 78 out of 98 on our bullish pennant scan, with a 62% historical win probability over a 1-6 trading days hold. Good setup based on our systematic scoring.
What is the entry, target, and stop loss for this setup?
The setup's reference price is $234.82, with a conservative target of $252.35 and a stop loss at $213.45.
What would invalidate this bullish pennant setup?
A close below the stop loss at $213.45 would invalidate the setup and suggest the pattern has failed.
How is the win probability calculated?
Win probability is a calibrated estimate of how similar historical bullish pennant setups performed over the following 10 trading days, drawn from a database of 370,000+ historical pattern detections across 6,000+ NYSE and NASDAQ stocks.